By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Miscellaneous antifungals > Terbinafine > Terbinafine Dosage
Miscellaneous antifungals
https://themeditary.com/dosage-information/terbinafine-dosage-6815.html

Terbinafine Dosage

Drug Detail:Terbinafine (Terbinafine [ ter-bin-na-feen ])

Drug Class: Miscellaneous antifungals

Contents
Uses Warnings Before Taking Dosage Side effects Interactions FAQ

Usual Adult Dose for Onychomycosis - Fingernail

Tablets: 250 mg orally once a day

Duration of therapy:

  • Fingernail onychomycosis: 6 weeks
  • Toenail onychomycosis: 12 weeks

Comments:
  • Before using this drug, patients should be evaluated for evidence of chronic or active liver disease.
  • Before starting therapy, appropriate nail specimens for laboratory testing (potassium hydroxide preparation, fungal culture, or nail biopsy) should be obtained to confirm the diagnosis of onychomycosis.
  • Optimal clinical effect observed some months after mycological cure and completion of therapy; related to time required for outgrowth of healthy nail.

Use: For the treatment of onychomycosis of the fingernail or toenail due to dermatophytes (tinea unguium)

Usual Adult Dose for Onychomycosis - Toenail

Tablets: 250 mg orally once a day

Duration of therapy:

  • Fingernail onychomycosis: 6 weeks
  • Toenail onychomycosis: 12 weeks

Comments:
  • Before using this drug, patients should be evaluated for evidence of chronic or active liver disease.
  • Before starting therapy, appropriate nail specimens for laboratory testing (potassium hydroxide preparation, fungal culture, or nail biopsy) should be obtained to confirm the diagnosis of onychomycosis.
  • Optimal clinical effect observed some months after mycological cure and completion of therapy; related to time required for outgrowth of healthy nail.

Use: For the treatment of onychomycosis of the fingernail or toenail due to dermatophytes (tinea unguium)

Usual Adult Dose for Tinea Capitis

Oral granules: 250 mg orally once a day for 6 weeks

Comments:

  • Before using this drug, patients should be evaluated for evidence of chronic or active liver disease.

Usual Adult Dose for Tinea Corporis

Some experts recommend:

  • Tablets: 250 mg orally once a day for 2 to 4 weeks

Usual Adult Dose for Tinea Cruris

Some experts recommend:

  • Tablets: 250 mg orally once a day for 2 to 4 weeks

Usual Adult Dose for Tinea Pedis

Some experts recommend:

  • Tablets: 250 mg orally once a day for 2 to 6 weeks

Usual Pediatric Dose for Tinea Capitis

4 years or older:
Oral granules:
Less than 25 kg: 125 mg orally once a day
25 to 35 kg: 187.5 mg orally once a day
Greater than 35 kg: 250 mg orally once a day

Duration of therapy: 6 weeks

Comments:

  • Before using this drug, patients should be evaluated for evidence of chronic or active liver disease.

For Children, Some Experts Recommend:
Tablets: 5 mg/kg/day orally

Based on weight:
10 to 20 kg: 62.5 mg orally once a day
21 to 40 kg: 125 mg orally once a day
41 kg or more: 250 mg orally once a day

Duration of therapy:
  • Trichophyton tonsurans infection: 2 to 4 weeks
  • Microsporum canis infection: Longer duration needed.

Renal Dose Adjustments

CrCl 50 mL/min or less: Data not available

Comments:

  • Drug clearance reduced by about 50% in patients with renal dysfunction (CrCl 50 mL/min or less) compared to those with normal renal function.

Liver Dose Adjustments

Chronic or active liver disease: Contraindicated

Comments:

  • Drug clearance reduced by about 50% in patients with liver cirrhosis compared to those with normal liver function.

Precautions

Safety and efficacy of the tablets have not been established in patients younger than 18 years with onychomycosis. Safety and efficacy of the oral granules have not been established in patients younger than 4 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:

  • Oral granules: Administer with food. Sprinkle the contents of each packet on a spoonful of pudding or other soft, nonacidic food (e.g., mashed potatoes) and swallow the entire spoonful without chewing; do not use applesauce or fruit-based foods. If 2 packets needed with each dose, may sprinkle both packet contents on 1 or 2 spoonfuls of nonacidic food
  • Consult the manufacturer product information regarding missed doses.

Storage requirements:
  • Oral granules: Store at 25C (77F); excursions permitted to 15C to 30C (59F to 86F).
  • Tablets: Store below 25C (77F) in tight container; protect from light.

General:
  • Clinical resolution may not be observed until several weeks after mycological cure.
  • Oral granules were not studied in geriatric patients.

Monitoring:
  • Hematologic: Complete blood counts in patients with known/suspected immunodeficiency if therapy continues beyond 6 weeks or in patients with clinical signs/symptoms suggestive of secondary infection
  • Hepatic: For evidence of chronic or active liver disease; liver function tests (before therapy, then periodically)
  • Psychiatric: For depressive symptoms

Patient advice:
  • Read the US FDA-approved Medication Guide; if using the oral granules, also read the Instructions for Use.
  • Minimize exposure to natural and artificial sunlight (tanning beds or ultraviolet A/B treatment) during therapy.
  • Contact physician or seek medical care immediately if any of the following symptoms develop: hives, mouth sores, blistering/peeling of skin, swelling (of face, lips, tongue, throat), problems swallowing/breathing.
  • Contact physician at once if symptoms of liver injury (persistent nausea, anorexia, fatigue, vomiting, right upper abdominal pain, jaundice, dark urine, pale stools) develop.
  • Consult physician if any signs of taste/smell disturbance, depressive symptoms, fever, skin eruption, lymph node enlargement, erythema, scaling, loss of pigment, or unusual photosensitivity (that can result in rash) occur.

Frequently asked questions

  • What are the most common skin conditions? (with photos)
  • What is the best over-the-counter nail fungus treatment?
  • What home remedies work well for toenail fungus?
  • How do I get rid of nail fungus?
Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by